Application of Chinese Medicine Nursing Techniques in the Sequelae of Pelvic Inflammatory Diseases: A Review

Sequelae of Pelvic Inflammatory Diseases (SPID) is a common and frequent disease in gynecology, which adversely affects women’s reproductive health and quality of life due to its prolonged course. In recent years, traditional Chinese medicine (TCM) in China has gradually shown its clinical advantages in the treatment of SPID. Therefore, the present review summarizes the etiology and pathogenesis of SPID, the evidence typology, and the clinical application effects of moxibustion, herbal retention enema, acupoint compresses, external application of traditional Chinese medicine, auricular pressure beans, tuina massage, traditional Chinese medicine gongfu, and other commonly used Chinese medicine nursing techniques, with the aim of providing references and experiences for the subsequent related studies.

Effect of Danzhi decoction on expression of angiogenesis factors in patients with sequelae of pelvic inflammatory disease

Objective:To investigate the efteets of traditional Chinese medicine.Danzhi decoction,on the expression angiogenesis factors in human endometrial cells during the sequelae of pelvic inflammatoty disease(SPID) and explore the role of Danzhi decction in improving the blood stasis microenvironment of SPID.Methods:A three-dimensional(3D) co—culture system including human vascular endothelial cells(VECs),endometrial stromal cells and glandular epithelial cells was established in vitro and treated with Danzhi decoction,sterilized water and aspirin respectively.A Milliplex multifunctional liquid chip technique was used to measure the expression levels of vascular endothelial growth factor(VEGF)—A/C/D,fibroblast growth factor-1/2.angiopoietin-2.epidermal growth factor(EGF) HB-EGF,bone morphogenetic protein-9.endoglin.endothehn-l.granulocyte colony stimulating factor,hepatocyte growth factor,interleukin-8,follistatin.placenta growth factor and leptin.The location of angiogenesis factors was monitored by immunofluorescence labeling and confocal laser scanning microscope3 D reconstruction.Results:Endometrial stromal cells and glandular epithelial cells were isolated and primary cultured for establishing a 3D co-culture system.The levels of VEGF—A/C/D in Danzhi decoction group and aspirin group were significantly lower than those in mock group(P<0.05).while there was no significant difference between Danzhi decoction group and aspirin group(P>0.05).Furthermore,the alterative location of VEGF—A/C/D was observed in the cytoplasm of endometrial glandular epithelial cells.Conclusions:Danzhi decoction mav inhibit the expression of VEGF in the blood stasis microenvironment of SPID by targeting the cytoplasm of endometrial glandular epithelial cell.

Research progress of traditional Chinese medicine nursing for pelvic inflammatory disease sequelae

Pelvic inflammatory disease refers to a group of female genital tr act on infec tious disease, mainly including endometritis, tubal phlogistic, oviduct ovarian abscess, if not 廿mely tr eatment of the disease is easy to become chr onic, now called pelvic inflammatory disease sequelae, clinical manifestations in chronic pelvic pain, recurrent pelvic inflammatory disease, affect women's physical and mental health. TCM nursing based on the basic theory of TCM, apply the overall view, the nursing method of syndrome differentiation, the traditional Chinese medicine nursing technique is widely used in the disease, such as traditional Chinese medicine enema, Chinese medicine external treatment, moxibustion, ear acupuncture point buries a seed, methods of modern nursing, has the characteristics of simple and cheap effect, can reduce the swelling fights, promoting blood circulation to remove blood stasis, relieve the pelvic congestion, promote drainage in abdominal and pelvic cavity and the absorption of bag piece, adjust the viscera function, obvious effect and has unique advantages, further prove the uniqueness of TCM nursing and safety, provide the basis for clinical treatment.

Research on the effect of kunfukang capsule on improving uterine microcirculation in patients with sequelae of pelvic inflammatory disease and its influence on levels of crp, gm-csf and mcp-1 in peripheral blood

Objective:To investigate the clinical effect of kunfukang capsule on improving uterine microcirculation in patients with sequelae of pelvic inflammatory disease, and to observe its influence on levels of CRP, GM-CSF and MCP-1 in peripheral blood.Methods: 126 patients with pelvic inflammatory disease sequelae admitted to our hospital from January 2017 to June 2018 were selected and divided into control group and observation group with 63 cases in each group according to the random number table method. Patients in the control group were given azithromycin tablets orally, while patients in the observation group were treated with kunfukang capsule on the basis of control group,7days for a course of treatment, 4 courses of continuous treatment. The purpose of this study was to compare the clinical effects of treatment between the two groups, evaluate the TCM syndrome score, observe the levels of CRP, GM-CSF and MCP-1 in uterine microcirculation and peripheral blood, and record the adverse reactions of patients during treatment.Results: The effective rate of 90.48% in the observation group was significantly higher than that in the control group of 77.78%(P<0.05). After treatment, the total score of TCM syndromes was significantly lower than that in the control group (P<0.05). The improvement of uterine microcirculation was more obvious, and the PI and RI were significantly decreased compared with the control group, while Vs, Vd and Vm were increased compared with the control group (P<0.05). The levels of CRP, GM-CSF and MCP-1 in peripheral blood were significantly lower than those in the control group (P<0.05). During the treatment, the adverse reaction rate of 7.94% in the observation group was significantly lower than that of the control group of 25.40% (P<0.05).Conclusion: Kun fu kang capsule combined with azithromycin is beneficial to reduce pelvic mass in sequelae of pelvic inflammatory disease and alleviate clinical symptoms. The mechanism may be related to improving the status of uterine microcirculation and inhibiting CRP, GM-CSF and MCP-1 levels in peripheral blood to reduce inflammatory infiltration of pelvic tissue, which is safe and reliable.

Application of Preventive Treatment Theory in the Treatment of Pelvic Inflammatory Disease

With a history of more than two thousand years, the theory of preventative treatment has been closely followed by the development of modern medical theories on the basis of inheritance by medical experts in the past dynasties, which has been constantly improved and enriched, and deeply applied in the prevention and treatment of serious and multiple diseases. It has achieved great benefits. For women with gynecological diseases, pelvic inflammatory disease patients accounted for a large proportion. Due to the lack of specificity in diagnosis and treatment, the condition is lingering and difficult to cure, so it seriously reduces the quality of life of women, thus affecting the harmony of family and society. From the perspective of prevention, according to the characteristics of each stage of the disease, this paper put forward substantive prevention suggestions and targeted treatment methods, ensuring preventing before disease, preventing progress after disease, and preventing reoccurring after recovery. It has important practical significance for the prevention and treatment of pelvic inflammatory diseases, as well as the development and inheritance of traditional Chinese medicine.

祛瘀通络方联合灌汤1号对盆腔炎性疾病后遗症患者炎症因子的影响

目的探讨祛瘀通络方联合灌汤1号对盆腔炎性疾病后遗症患者炎症因子的影响。方法选取100例盆腔炎性疾病后遗症患者,随机分为对照组与治疗组,每组50例,对照组采用桂枝茯苓丸口服治疗,治疗组采用祛瘀通络方口服联合灌汤1号保留灌肠治疗,疗程3个月。观察中医证候积分、局部症状及血清白细胞介素-8(Interleukin-8,IL-8)、白细胞介素-6(Interleukin-6,IL-6)、肿瘤坏死因子(Tumor necrosis factor-α,TNF-α)变化。结果两组患者治疗前中医证候积分比较差异无统计学意义(P>0.05),治疗后中医证候积分较治疗前下降,治疗组下降程度明显大于对照组,比较差异有统计学意义(P<0.05);两组患者治疗前局部症状评分比较差异无统计学意义(P>0.05),治疗后局部症状的评分较治疗前下降,治疗组下降程度明显大于对照组,比较差异有统计学意义(P<0.05);两组患者治疗前血清IL-8、IL-6、TNF-α比较差异无统计学意义(P>0.05),治疗后IL-8、IL-6、TNF-α水平较治疗前下降,治疗组下降程度明显大于对照组,比较差异有统计学意义(P<0.05);治疗组治疗疗效明显优于对照组(P<0.05),治疗组治疗总有效率为96.00%(48/50),高于对照组80.00%(40/50),比较差异有统计学意义(P<0.05)。结论盆腔炎性疾病后遗症患者采用祛瘀通络方联合灌汤1号治疗,可改善自觉症状及妇科阳性体征,降低血清促炎因子水平,提高治疗疗效。

中医药干预盆腔炎性疾病后遗症作用机制研究概况

盆腔炎性疾病后遗症因迁延难愈、反复发作,严重影响女性生殖健康和生活质量。回顾近10年中医药通过调控转化生长因子-β/Smads蛋白(TGF-β/Smads)、丝裂原活化蛋白激酶(MAPKs)、酪氨酸激酶/信号转导子和转录激活子(JAK/STAT)、核转录因子-κB(NF-κB)、脂肪酸合成酶/脂肪酸合成酶配体(Fas/FasL)、Toll样受体(TLRs)等信号通路干预盆腔炎性疾病后遗症的研究,分析并总结了不同信号通路的作用机制及研究要点,以期为盆腔炎性疾病后遗症的治疗提供有效靶点及理论依据。参考文献51篇。

妇科千金方及其拆方对盆腔炎性疾病后遗症大鼠的作用

目的研究妇科千金方及其拆方对盆腔炎性疾病后遗症大鼠的作用。方法SD大鼠随机分为正常组、假手术组、模型组、康妇炎组(0.756 g/kg)、妇科千金方组(2.7 g/kg)、抑菌方组(2.7 g/kg)、抗炎方组(2.7 g/kg)、补益方组(2.7 g/kg),灌胃给予相应药物28 d后处死,计算子宫、脾脏、胸腺、肝脏指数,肉眼观察大鼠、输卵管形态学改变,HE染色观察大鼠子宫、输卵管组织病理学变化,ELISA法检测大鼠血清IL-1β、IL-18、IL-6水平,Western blot法检测大鼠子宫组织TGF-β1、CTGF、NLRP3、caspase-1、IL-18蛋白表达,流式细胞术检测大鼠脾脏组织CD4、CD8表达。结果与模型组比较,妇科千金方组、抑菌方组、抗炎方组、补益方组大鼠子宫、脾脏、胸腺指数均降低(P<0.01);妇科千金方组、抗炎方组大鼠子宫肿胀减轻,子宫内膜腺体增多,炎性渗出减轻(P<0.01),血清IL-1β、IL-18、IL-6水平降低(P<0.01);妇科千金方组、抗炎方组、补益组大鼠子宫组织TGF-β1、CTGF蛋白表达降低(P<0.05);妇科千金方组、抗炎方组大鼠子宫组织NLRP3、caspase-1、IL-18蛋白表达降低(P<0.01);妇科千金方组、补益组CD4^(+)/CD8^(+)比值升高(P<0.01)。结论妇科千金方及其拆方对盆腔炎性疾病后遗症大鼠具有保护作用,其抗炎作用机制可能是通过抑制NLRP3小体的活化,从而阻碍caspase-1的活化,降低促炎症因子IL-18的分泌及释放,抑制细胞焦亡而发挥抗炎作用。

柏薏灌肠液联合丹白颗粒治疗盆腔炎性疾病后遗症(湿热瘀结证)的临床研究

目的:探讨柏薏灌肠液联合丹白颗粒治疗盆腔炎性疾病后遗症(湿热瘀结证)的临床疗效。方法:选取2021年3月至2023年3月该院收治的盆腔炎性疾病后遗症(湿热瘀结证)患者90例,采用随机数字表法分为中药灌肠组、中药颗粒组和联合组,每组30例。中药灌肠组患者采用常规治疗+柏薏灌肠液,中药颗粒组患者采用常规治疗+丹白颗粒,联合组患者采用常规治疗+柏薏灌肠液+丹白颗粒。治疗3个月经周期后,评估三组患者的临床疗效、中医证候积分、血流动力学、炎症因子和治疗安全性。结果:联合组患者的总有效率为93.33%(28/30),高于中药灌肠组、中药颗粒组的70.00%(21/30)、66.67%(20/30),差异均有统计学意义(P<0.05)。治疗后,联合组患者中医证候积分(包括腰骶胀痛、经行不畅、带下增多和舌红苔黄积分)低于中药灌肠组、中药颗粒组,差异均有统计学意义(P<0.05)。治疗后,联合组患者子宫动脉收缩期最大流速、舒张末期最大流速和搏动指数高于中药灌肠组、中药颗粒组,阻力指数低于中药灌肠组、中药颗粒组,差异均有统计学意义(P<0.05)。治疗后,联合组患者炎症因子[白细胞介素18、前列腺素E2和β淀粉样前体蛋白]水平低于中药灌肠组、中药颗粒组,差异均有统计学意义(P<0.05)。联合组、中药灌肠组和中药颗粒组患者的不良反应发生率分别为13.33%(4/30)、10.00%(3/30)和6.67%(2/30),组间差异无统计学意义(P>0.05)。结论:柏薏灌肠液联合丹白颗粒治疗盆腔炎性疾病后遗症(湿热瘀结证)的效果良好,可改善患者中医证候,提高盆腔子宫动脉血流动力学,抑制炎症因子水平,安全性良好。

四逆散加味联合中药保留灌肠治疗气滞血瘀型盆腔炎后遗症的临床观察

目的:比较四逆散加味及四逆散加味联合中药保留灌肠治疗气滞血瘀型盆腔炎后遗症的临床疗效。方法:将60例气滞血瘀型盆腔炎后遗症患者随机分为对照组和观察组,每组30例,对照组给予四逆散加味口服治疗,观察组在口服四逆散加味基础上增加中药保留灌肠治疗。每月用药3周,经期停药1周,连续治疗3个月。比较2组患者治疗有效率,以及治疗前后的局部体征积分、中医证候总积分。结果:对照组治疗有效率80%,观察组有效率90%。2组患者治疗后局部体征积分均较治疗前改善,差异有统计学意义(P<0.05);组间比较,治疗后局部体征积分差异无统计学意义(P=0.61)。2组患者治疗后中医证候总积分较治疗前均有改善,差异有统计学意义(P<0.05);观察组治疗后中医证候总积分改善优于对照组,差异有统计学意义(P<0.05)。结论:四逆散加味治疗气滞血瘀型盆腔炎后遗症有良好的治疗效果,配合中药保留灌肠可进一步改善中医证候总积分。

论风药在盆腔炎性疾病后遗症治疗中的应用

盆腔炎性疾病后遗症是妇科常见的慢性疾病,其成因复杂,病程长,缠绵难愈,对女性的生殖健康与正常生活都产生了严重影响。风药能祛除风疾并兼有风木属性,具有“升、行、透、窜、动”的特性,针对盆腔炎性疾病后遗症“湿、瘀、郁、虚”的病因病机,能从“助运胜湿、活血化瘀、开散气结、补而不滞”四个方面发挥协同作用。文章从盆腔炎性疾病后遗症的病因病机出发,探讨了风药在本病治疗中的机理及应用,并附验案一则,为该病的中医治疗提供参考。

妇炎清颗粒治疗湿热瘀结型盆腔炎性疾病后遗症临床研究

目的评价妇炎清颗粒对盆腔炎性疾病后遗症(湿热瘀结证)的临床疗效。方法采用随机对照、双盲双模拟临床研究设计方法,5个试验中心300例盆腔炎性疾病后遗症(湿热瘀结证)患者随机分为试验组(150例)与对照组(150例)。试验组予妇炎清颗粒及金刚藤胶囊模拟剂口服,对照组予金刚藤胶囊及妇炎清颗粒模拟剂口服,疗程4周。将治疗前、治疗后及治疗结束后12周两组的临床总疗效、中医症状积分、盆腔疼痛评分疗效、盆腔积液及包块的恢复、宫颈分泌物恢复、复发率等情况进行比较。结果300例患者中,符合方案有效病例282例,试验组145例,对照组137例。疗程结束后,试验组、对照组总有效率分别为91.03%(132/145)、67.88%(93/137),试验组优于对照组(P<0.05);试验组治疗后的中医症状积分减少程度对比对照组更佳(P<0.05);试验组与对照组盆腔疼痛疗效有效率分别为93.10%(135/145)和75.91%(104/137),试验组优于对照组(P<0.05);两组盆腔内积液、包块恢复情况比较,试验组优于对照组(χ^(2)=15.633,P<0.05);宫颈分泌物恢复情况试验组优于对照组(χ^(2)=8.560,P<0.05);治疗结束后12周进行对比,试验组治疗有效患者的临床症状复发率较对照组更低(P<0.05);两组不良反应发生率在治疗过程中对比差异无统计学意义(P>0.05),两组药物均有较高安全性。结论妇炎清颗粒治疗盆腔炎性疾病后遗症(湿热瘀结证)临床疗效确切,在临床综合总疗效、中医症状总积分和单个症状积分的疗效等方面均优于金刚藤胶囊。

名中医丛慧芳从“正虚邪恋”论治“寒地”盆腔炎性疾病后遗症经验

总结丛慧芳教授治疗盆腔炎性疾病后遗症的临床经验。丛慧芳教授基于女性胞宫的生理独特性,认为胞宫为至阴之地以及地处北方的地域性,再结合疾病迁延难愈的特性,总结正虚邪恋是此病的关键病机,病位虽在胞宫,病机为冲任受损,但与五脏相因,切不可一味攻伐祛湿清热,认为“虚”和“瘀”是导致本病发生和经久不愈的关键因素。此时瘀血同时作为病理产物和继发病因,机体无力自主,缠绵痛苦势所必然。由此在治疗时以扶正祛邪为其根本治疗思路,唯清热除湿恐难取效,亦非独驱邪攻瘕以复其能,故丛慧芳教授在此基础上采取温散祛瘀之法,使正气匡扶,邪气可散,余症自瘥。

自拟清热逐秽饮保留灌肠联合抗生素治疗盆腔炎性疾病后遗症疗效研究

目的探讨自拟清热逐秽饮保留灌肠联合抗生素治疗盆腔炎性疾病后遗症(SPID)效果。方法回顾性分析2018年1月—2022年1月医院收治的76例SPID湿热瘀阻证女性患者,按不同的治疗方法分为两组,各38例。对照组参考指南采取常规抗生素干预;治疗组于对照组的基础上采取自拟清热逐秽饮保留灌肠干预。两组连续治疗3个月。比较两组疼痛程度、血常规指标、临床疗效以及血清C反应蛋白(CRP)与降钙素原(PCT)水平。结果治疗3个月后,两组下腹部、腰骶部评分均明显降低,且治疗组降低更明显(P<0.01);治疗3个月后,两组白细胞与中性粒细胞计数显著降低,且治疗组降低更显著(P<0.01);治疗3个月后,治疗组的总有效率较对照组上调更加明显(P<0.05);治疗3个月后,两组血清CRP与PCT水平明显降低,且治疗组降低更显著(P<0.01)。结论自拟清热逐秽饮保留灌肠联合抗生素治疗SPID疗效明显,能显著减少患者疼痛,抑制炎症反应。

中药治疗盆腔炎性疾病后遗症作用机制研究进展

目的研究单味中药及复方治疗盆腔炎性疾病后遗症的作用机制。方法对Pubmed、Web of Science、中国知网和万方等数据库进行检索,寻找建库至2023年3月以来关于中药治疗SPID及作用机制的相关文献,并对文献进行归纳整理。结果共纳入文献428篇,从纳入文献中筛选出从调节细胞因子和炎症介质分泌水平、促进炎症细胞凋亡、抑制脂质过氧化、抑制组织纤维化、改善血液循环、调节代谢途径和细胞信号转导、调节免疫能力等方面报道单味中药及复方治疗盆腔炎性疾病的作用机制。结论为中药治疗盆腔炎性疾病后遗症作用机制进行深入研究,并对其新药研发提供参考。

基于数据挖掘的盆腔炎性疾病后遗症动物模型分析

目的梳理盆腔炎性疾病后遗症(sequelae of pelvic inflammatory disease,SPID)动物模型特点,为规范造模流程、提高成模率提供参考。方法检索近40年有关SPID动物模型的文献,总结并分析动物种类、造模方法、阳性对照药、评价指标等。结果纳入243篇文献,多采用苯酚胶浆法或微生物感染法诱导大鼠建立SPID模型,造模周期在14~16 d为主,大多以盆腔组织形态观察和苏木素-伊红(HE)染色判定模型成功与否。中医病症结合模型研究较少。结论SPID动物模型造模方法缺乏一致性的判定标准,建议综合动物行为学变化、盆腔组织形态学改变以及病理等进行评价。同时,中医证候造模缺乏有效的方法和评价标准,有待进一步研究发展。

桂枝茯苓丸治疗盆腔炎性疾病后遗症研究进展

桂枝茯苓丸出自《金匮要略》,为临床常用经方,具有温经活血、化瘀通络的功效,广泛用于盆腔炎性疾病后遗症(sequelae of pelvic inflammatory diseases,SPID)的治疗。SPID主要表现为盆腔内组织广泛增生、粘连,形成瘢痕,容易导致输卵管的堵塞,进而发展为不孕症。其病因及发病机制多与免疫、病原体感染等多种因素相关。动物实验及临床研究均表明桂枝茯苓丸治疗SPID具有多层次、多途径、多靶点的优势。在临床应用上,桂枝茯苓丸化裁或其中成药联合常规西医治疗SPID效果明确,能明显改善患者症状及体征,并可有效地控制疾病的发展,提高病人的生活质量,不良反应小,安全性高。但该方的实验手段、研究方案等尚需改进,其作用机制也需进一步研究。该文通过查阅和整理有关文献,对近几年来桂枝茯苓丸治疗SPID的机制和临床研究成果进行了系统性的归纳和综合分析,同时也对其存在的缺陷提出建议。以期为桂枝茯苓丸的进一步应用提供理论和数据支持,并为其在临床上的合理使用提供实践指导。

从铁死亡角度探讨盆炎丸治疗盆腔炎后遗症的作用机制

目的基于生物信息学方法从铁死亡的角度探讨盆炎丸治疗盆腔炎后遗症(SPID)的作用机制。方法(1)取40只大鼠,其中30只大鼠采用苯酚胶浆法进行SPID造模,并随机将其分为模型组、盆炎丸组及西药阳性对照(阿奇霉素)组,另10只大鼠作为假手术组,仅进行开关腹手术操作而不注射苯酚胶浆。造模完成后,给予盆炎丸组大鼠盆炎丸0.27 g/(100 g·d)灌胃,给予阿奇霉素组大鼠阿奇霉素4.5 mg/(100 g·d)灌胃,给予假手术组与模型组大鼠等量生理盐水灌胃。干预4周后取小鼠子宫组织进行肉眼及HE染色观察。(2)利用GEO数据库检索与SPID相关的数据集,并对数据集中的靶点进行差异表达分析,获得SPID相关靶点。通过FerrDb平台收集铁死亡相关靶点。通过本草组鉴平台收集盆炎丸组成药物对应的作用靶点。将上述靶点取交集获得盆炎丸干预铁死亡治疗SPID的关键靶点。针对关键靶点,构建蛋白-蛋白相互作用(PPI)网络并进行基因本体论(GO)富集分析。通过Cytoscape软件构建中药-成分-靶点网络,最后对关键靶点蛋白和对应的中药单体成分进行分子对接分析。结果(1)经盆炎丸干预后,SPID大鼠模型子宫组织水肿明显减轻,子宫结构大致恢复正常,上皮排列整齐,未见变性脱落。(2)共得到SPID相关靶点3073个,铁死亡相关靶点388个,盆炎丸作用靶点395个,取交集后获得NOS2、RELA、HNF4A、MAPK1、PTEN、SMAD7、GSK3B、TGFB1、RB1、SRC 10个关键靶点。其中,SRC、PTEN、TGFB1为PPI网络中的关键节点。GO富集分析结果显示,关键靶点涉及的生物过程包括蛋白质修饰过程的负调控等。在中药-成分-靶点网络中,最关键中药为甘草,最关键靶点为MAPK1,最关键中药单体成分为芹菜素。分子对接结果显示,芹菜素与MAPK1的对接能量最低,发挥作用的可能性最大。结论盆炎丸可通过芹菜素等多个成分,干预铁死亡相关靶点(RELA、MAPK1、TGFB1、SRC等)治疗SPID,具体机制与抗慢性炎症反应与组织纤维化相关。

中药外治法治疗盆腔炎性疾病后遗症所致慢性盆腔痛的循证研究及临床验证

目的获得临床医师对于盆腔炎性疾病后遗症所致慢性盆腔痛(SPID-CPP)外治中药的推荐用药。方法通过两轮德尔菲法专家问卷的形式,获得临床医师对于盆腔炎性疾病后遗症最为关注的临床问题并进行重要性积分,以获取临床问题。再通过文献检索纳入系统评价及随机对照试验,进行偏倚分析以获得证据体,得出初步推荐意见,再经过一轮德尔菲法问卷调查后得出最终推荐意见,再经过多中心临床试验加以验证。结果三轮德尔菲法的专家积极程度、专家意见集中度及专家权威系数均较高,结果可信度较好;91.11%的临床医师强推荐清热除湿、化瘀止痛类中成药用于湿热瘀结证SPID-CPP的外治;临床研究显示清热除湿、化瘀止痛类中药保留灌肠治疗湿热瘀结证SPID-CPP的总有效率为87.22%。结论临床医师对于中药外治法治疗SPID-CPP的关注度最高,在具体用药方面更倾向于使用中成药制剂,其中化瘀散结灌肠液治疗SPID-CPP湿热瘀结证的推荐意见最强。对于临床常见的湿热瘀结型SPID-CPP,清热除湿、化瘀止痛类中药保留灌肠有效率高。

基于久病入络理论探讨徐氏妇科治疗盆腔炎性疾病后遗症经验

盆腔炎性疾病后遗症是盆腔炎性疾病的遗留病变,有易复发,症状迁延日久的特点,对患者机体及心理健康造成极大影响。庐江徐氏妇科为安徽省自明清以来三大妇科流派之一,2022年5月被列入第6批安徽省级非物质文化遗产代表性项目名录。庐江徐氏妇科经过5代家传和3代师承,学术经验甚广。作者从久病入络理论出发,探讨庐江徐氏妇科治疗盆腔炎性疾病后遗症的相关经验。